Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells
- PMID: 15172452
- DOI: 10.1016/j.humimm.2004.02.018
Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells
Abstract
H2-deleted, HLA-A2, or HLA-B7 transgenic mice were used to identify new human cytomegalovirus (HCMV)-derived major histocompatibility complex class I-restricted epitopes. Three different approaches for mice immunization were compared for their ability to induce a cytotoxic CD8(+) T cell (CTL) response: (1). inoculation of infectious HCMV, (2). injection of immunogenic synthetic peptides, and (3). infection with a newly designed HIV-derived central DNA flap positive lentiviral vector encoding the chimeric IE1-pp65 protein (Trip-IE1-pp65). Targets pulsed with either known immunogenic peptides or computer predicted ones were used to characterize CTL. Most of the mice immunized with the pp65 (495-NLVPMVATV-503) immunodominant peptide responded after one injection whereas only two of six mice responded to two successive inoculations with HCMV. Infection of mice with Trip-IE1-pp65 induced activation and expansion of CTL directed against peptides from both pp65 and IE1 and allowed identification of new epitopes. We further demonstrated the high capacity of monocyte-macrophage cells transduced with Trip-IE1-pp65 to activate and expand CTL directed against pp65 from peripheral blood mononuclear cells of HCMV-seropositive donors. Altogether these results suggest that Trip-IE1-pp65 is a powerful construct both to characterize new epitopes in combination with human leukocyte antigen-transgenic mice immunization and to provide an alternative to the use of known infectious and noninfectious approaches to expand effector T cells for adoptive immunotherapy.
Similar articles
-
Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.Virology. 2002 Apr 10;295(2):208-16. doi: 10.1006/viro.2001.1335. Virology. 2002. PMID: 12033779
-
Refinement in the production and purification of recombinant HCMV IE1-pp65 protein for the generation of epitope-specific T cell immunity.Protein Expr Purif. 2008 Sep;61(1):22-30. doi: 10.1016/j.pep.2008.05.001. Epub 2008 May 14. Protein Expr Purif. 2008. PMID: 18539483
-
Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.J Virol. 2001 Sep;75(17):7840-7. doi: 10.1128/jvi.75.17.7840-7847.2001. J Virol. 2001. PMID: 11483727 Free PMC article.
-
Progress made towards the development of a CMV peptide vaccine.Hum Immunol. 2004 May;65(5):544-9. doi: 10.1016/j.humimm.2004.02.005. Hum Immunol. 2004. PMID: 15172455 Review.
-
CD8(+) T-cell immunity to cytomegalovirus.Hum Immunol. 2004 May;65(5):456-64. doi: 10.1016/j.humimm.2004.02.014. Hum Immunol. 2004. PMID: 15172445 Review.
Cited by
-
Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.Vaccine. 2008 Dec 2;26(51):6508-28. doi: 10.1016/j.vaccine.2008.09.044. Vaccine. 2008. PMID: 18838097 Free PMC article. Review.
-
Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy.Cancer Immunol Immunother. 2006 Aug;55(8):1011-6. doi: 10.1007/s00262-005-0095-5. Epub 2005 Nov 26. Cancer Immunol Immunother. 2006. PMID: 16311731 Free PMC article.
-
Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine.PLoS One. 2008;3(12):e3973. doi: 10.1371/journal.pone.0003973. Epub 2008 Dec 19. PLoS One. 2008. PMID: 19096527 Free PMC article.
-
Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV.Viruses. 2019 Dec 28;12(1):35. doi: 10.3390/v12010035. Viruses. 2019. PMID: 31905677 Free PMC article. Review.
-
A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector.Virology. 2008 Aug 1;377(2):379-90. doi: 10.1016/j.virol.2008.04.034. Epub 2008 Jun 5. Virology. 2008. PMID: 18538366 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials